Zepp Health makes the Amazfit line of smartwatches and fitness bands, sold mainly through its own app ecosystem and online retail channels in China and abroad. Its gross margin of 38.6% is respectable for a hardware maker, and revenue growth of 6.9% is positive, but operating margin of -19.4% and ROE of -21.2% show the cost base is not yet covering the business. At a $47M market cap and a forward P/E of 3.1, the market is pricing in deep skepticism about whether that gap closes. The score of 33/100 and absence from any index suggest the name is too small and too loss-making to attract institutional attention, so a deeper look would need to test whether operating losses are narrowing and whether top-line growth can hold without further cash burn.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 23 Oct 2026, 01:52 CEST | ACCE price target | $2.50 | $3.20 | $2.66 |
| 15 Oct 2026, 00:00 CEST | ACCE price target | $3.20 | first publication | $3.55 |
| 5 Oct 2026, 00:00 CEST | Fair value | $3.07 | $3.12 | $3.82 |
| 26 Sept 2026, 00:00 CEST | Fair value | $3.12 | $3.19 | $4.12 |
| 23 Sept 2026, 00:00 CEST | Fair value | $3.19 | $3.15 | $4.39 |
| 18 Sept 2026, 00:00 CEST | Fair value | $3.15 | $3.31 | $4.26 |
| 15 Sept 2026, 00:00 CEST | Fair value | $3.31 | $3.54 | $4.58 |
| 10 Sept 2026, 00:00 CEST | Fair value | $3.54 | $3.47 | $4.92 |
| 7 Sept 2026, 00:00 CEST | Fair value | $3.47 | $3.52 | $4.80 |
| 4 Sept 2026, 00:00 CEST | Fair value | $3.52 | $3.47 | $4.86 |
Answered from Zepp Health Corporation American depositary shares each representing sixteen Class A ordinary shares fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| ZEPP Zepp Health Corporation American depositary shares each representing sixteen Class A ordinary shares | $2.61 | - | - | - | -21.2% | 30 | 33 |
| KOSS Koss Corporation Common Stock | $3.46 | - | - | - | -1.3% | 43 | 35 |
| UEIC Universal Electronics Inc. Common Stock | $5.24 | - | - | - | -10.2% | 44 | 60 |
| ALJXR.PA Archos S.A. | €0.23 | - | - | 11.7x | 24.4% | 44 | 72 |
| FOXX Foxx Development Holdings Inc. Common Stock | $2.00 | - | - | - | 0.0% | 16 | 16 |
| VUZI Vuzix Corporation Common Stock | $2.06 | - | - | - | -94.4% | 31 | 16 |
| KJELL.ST Kjell Group AB (publ) | kr 19.60 | kr 9 | 107% above | - | -37.8% | 34 | 58 |
Where ZEPP ranks against its sector peers on each metric.